Malik Fady Ibraham — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Malik Fady Ibraham has filed 7 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $6.22M.

Profile

Fady Ibraham Malik is an executive in the biopharmaceutical industry, currently serving as the Executive Vice President of Research and Development at Cytokinetics Inc. He has also held a similar role at Rocket Pharmaceuticals, contributing to the development of innovative treatments for serious diseases.

Board memberships

• Cytokinetics Inc
• Rocket Pharmaceuticals, Inc.

Awards & honors

• Leadership in drug development
• Contributions to biopharmaceutical innovations
• Executive roles in multiple companies

Recent Transactions

Companies — Last 90 Days

• CYTOKINETICS INC (CYTK) — 6 filings, last 2026-07-07
• ROCKET PHARMACEUTICALS, INC. (RCKT) — 1 filings, last 2026-07-06

Frequently Asked Questions

Who is Malik Fady Ibraham?

Fady Ibraham Malik is an executive in the biopharmaceutical industry, currently serving as the Executive Vice President of Research and Development at Cytokinetics Inc. He has also held a similar role at Rocket Pharmaceuticals, contributing to the development of innovative treatments for serious diseases.…

How many SEC Form 4 filings has Malik Fady Ibraham submitted recently?

7 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Malik Fady Ibraham been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 37 open-market sales ($6.22M) across all tracked filings.

Where can I see all of Malik Fady Ibraham's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week